Team:Calgary/Project/PostRegionals
From 2013.igem.org
Final System
Final System
Our Sensor
The goal of our project this summer was to design a biosensor to rapidly identify cattle known as super-shedders. We are building a DNA-based biosensor as it is more reliable and cheaper than a protein-based sensor; antibodies would raise the cost of our system and the proteins that they target can get degraded during the sample preparation, whereas DNA is much more stable. A DNA-based sensor also enabled us to target a broader range of harmful E.coli (EHEC). Over the span of our project, the design of our system was influenced by our conversations with industry stakeholders . Their feedback revealed three design considerations which we would have to incorporate into our prototype. First, it would have to be cheap so that it could be scaled-up to entire feedlot or processing operation. Second, it would have to be easy to use by non-laboratory employees in the field. And third, it would have to provide a definitive measure of E.coli shedding levels within an hour to be used during routine check-up procedures or pre-processing. Our solution is the
Can we detect DNA with specificity?
We ordered 60mer FAM-labeled [A] (target sequence for TALEA) and FAM-labeled [B] (target sequence for TALEB) oligos and hybridized them with their reverse complement oligo to make double stranded pieces of DNA containing the target sequence of our TALEs. Using these target sequences and following the TALE Nitrocellulose Functionality Assay, we showed that TALEs bind their target sequence. We incubated Ferritin fused to an E coil to TALE fused to a K coil to make the ferriTALE complex. The complex was then blotted on strips of nitrocellulose paper. The strips were then blocked with milk and soaked in the appropriate DNA solution. Finally, the strips were washed and imaged. We showed that not only TALEs bind DNA (figure 24 and 25), they are also specific for their own target site (Figure 26).
Can our coils bind?
After putting in gratuitous effort to build parts containing our coils and successfully purifying these proteins we wanted to determine if the E and K coils interacted with each other. In order to characterize coil-coil interaction we performed an immunoprecipitation (IP) assay. We built a GFP with an E coil ( BBa_K1189014) and we also built TALE-B with a K-coil (BBa_K1189030). To characterize the binding of the coils we pulled down with either an immunoglobulin G antibody (IgG) that serves as a negative control or with GFP antibody. The idea behind this experiment is to pull down the E coil which is fused to GFP with a GFP antibody and then probe with a anti-his antibody which recognizes the his tag on the TALE fused to the K coil. Upon interaction between the E and K coils we will see an output at approximately 86 kDa when probed with a His-antibody as seen in Figure 7. Our test groups included the coils by themselves and both the E and K coils put together in solution. As seen in Figure 7 a band appears only when we pull E and K coil with a GFP and probe with an anti-his antibody indicating the presence of both GFP and TALE in the elution solution indicating that the coils interact with each other.
How does the use of Coils versus Direct Fusions of TALEs Affect our Prussian Blue reporter?
After successfully confirming that we could convert our own ferritin proteins that were produced from the parts we constructed (BBa_K1189018, BBa_K1189021) into Prussian blue ferritin the next step was to evaluate how the design of our parts could potentially affect the reporter activity of our Prussian blue ferritin. Based on the spatial modelling performed by our team it was suggested that assembly of the ferritin nanoparticle with TALE proteins directly fused was highly unlikely. This is because the TALE proteins are significantly larger than the ferritin subunits. Their size would likely result in steric hindrance and prevent the assembly of the full ferritin protein. In order to test the predictions put forward by our modelling we ensured that our protein samples were balanced in order to have the same number ferritin cores in each sample. The catalytic activity of these proteins was then compared. From the data gathered we saw that the Prussian blue ferritin with fused coils (even if TALES are additionally bound to the ferritin via coils) was more effective as a reporter than having the TALE proteins directly fused to the ferritin nanoparticle (Figure 19). The results from this experiment suggest that the predictions made by our model were correct. Using coils however alleviates this issue as these coils are small and would not interfere in the ferritin self-assembly but can be used to attach our TALES to create the FerriTALE.
Our Final System: Putting it all together
Can we successfully capture our DNA with our detectors with specificity and report it?
Finally, we wanted to see if the TALE capture assay works (figure 17). In order to do this, we blotted TALEB fused to a K coil (BBa_K1189030) was blotted on a nitrocellulose strip. Subsequently the strips were blocked with 5% skimmed milk in TBST buffer. The strips were then washed and soaked in a solution containing [A] and [B] on the same plasmid(BBa_K1189006). The strips were then washed again with TALE binding buffer and soaked in a solution containing TALEA+β-lac (BBa_K1189031). Then a blot dot was done on the strips with β-lactamase primary antibody and an hrp conjugated secondary antibody. This assay demonstrated that the TALEs can capture DNA.
In order to demonstrate that we can successfully capture target DNA with two TALEs we did a capture TALE assay. TALE B was incubated with DNA containing target sites for TALE A and TALE B and blotted on nitrocellulose. After blocking and washing, TALE A β-lactamase fusion (BBa_K1189031) was added to the nitrocellulose strips. The strips were transferred into a 96 well plate to which a benzylpenicillin substrate solution with phenol red was added. If the TALE A β-lactamase fusion bound to the target site for TALE A then the solution will change colour from pink to clear. If TALE A β-lactamase fusion was not present, the solution will remain pink. We can show that the first four samples which have TALE B with DNA for TALE A and TALE B show a colour change indicating that we are successfully capturing the target DNA and reporting it. Furthermore we can also show that when we add non-specific DNA we do not see a colour change demonstrating that we can successfully capture only specific DNA and report its presence with an easy visual colourimetric output.
This assay shows that we can capture our target DNA with two detector TALEs with specificity. Additionally, we can report whether that DNA has been captured and is present in the sample, which is an essential concept for our sensor system.
Full System Kinetic Model
With a preliminary understanding of how our system works we proceeded to quantitatively model our entire system. To do this we used the kinetic constants found in our experiments from the TALE and prussian blue ferritin characterization to build a deterministic model in Scilab. We modelled the binding of an immobilized TALE to target DNA in solution and then the subsequent binding of one of our ferriTALEs. We then used the Michaelis-Menten kinetics of our prussian blue ferritin to calculate how quickly it converts TMB into the coloured product that we can see.
When we assembled our reactions into differential equations, we generated 6 equations to cover the change in our 6 variables over time. When this equation was run with the amount of DNA present in a super shedding cow the output chemical, X, changes over time as shown below.
The red line on the figure above shows when the reaction reaches 22.176 µM, which is the concentration at which a blue dot or line becomes visible. This value was calculated based on the kinetic parameters we determined in our characterization of prussian blue ferritin. This takes approximately 4.9 minutes, meaning that we will be able to see a visible response from a super shedding cow in less than 5 minutes!
Further Characterization of our parts
Additionally, we have demonstrated the same pH change of benzylpenicillin to penicillinoic acid by the TALE A β-lactamase fusion (BBa_K1189031) with bromothymol blue. The pH change causes the bromothymol blue to change in colour from blue to yellow as it gets more acidic (Figure 11 & 12). In the presence of TALE A β-lactamase fusion we see the colour change to yellow whereas the negatives not containing TALE A β-lactamase fusion remains blue (Figure 11). We did a kinetic analysis at 616 nm every 30 seconds and as the blue colour disappears, the absorbance at 616 nm decreases (Figure 12). Therefore, the lower the decrease the better the TALE A β-lactamase fusion reporter activity. Our kinetic activity shows that the biggest decrease is in our positive recombinant β-lactamase followed by the TALE A β-lactamase fusion at 10 micrograms. This decrease is lessened as we decrease the amount of TALE A β-lactamase fusion. We can also show that in our negatives with no TALE A β-lactamase fusion we do not have a decrease in absorbance. We have demonstrated the reporter activity both qualitatively (Figure 10 & 11) and quantitatively (Figure 12).
Conclusion
We have been able to demonstrate the function our final system capable of capturing DNA with an immobilized TALE, exposing a second TALE with a reporter molecule, and detection of that reporter molecule. In our project we have utilized modelling at every step of the way to inform the course of our experiments, as well as to feed our data back into our models to generate better predictions, utilizing the full design cycle for our system. Through our characterization of parts from previous teams and the ones we have submitted ourselves we have created a collection of well documented parts that can be easily used and modified by any future team for a wide variety of applications. Finally, we are bringing our system into the final prototype stages through our work with nitrocellulose, such that our work can move beyond the proof of principle stages and make an impact in the world to reduce the risk of EHEC harming people in the future.